Latest kidney cancer news
Ipilimumab plus nivolumab combination approved for use on the NHS
The National Institute for Health and Care Excellence (NICE) has [...]
Liquid biomarkers in advanced kidney cancer
In a presentation at the 19th Meeting of the European [...]
Artificial intelligence for kidney cancer diagnosis
In a presentation at the 19th Meeting of the European Association [...]
3D imaging in robot-assisted partial nephrectomy
In a presentation at the 19th Meeting of the European [...]
The Health and Care Bill
The Health and Care Bill is being debated in the [...]
Patient-reported outcomes with nivolumab plus cabozantinib in advanced kidney cancer
Ongoing results from the phase 3 CheckMate-9ER clinical trial with nivolumab plus cabozantinib have been [...]
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo kidney cancer sunitinib cabozantinib Sutent progression-free survival NHS England biomarkers ipilimumab pembrolizumab Cabometyx axitinib COVID-19 cancer survival non-clear cell kidney cancer VEGF inhibitors Inlyta coronavirus risk factors Yervoy adjuvant therapy Keytruda targeted therapy metastases papillary RCC everolimus biological markers ASCO Afinitor cancer outcomes first-line treatment NICEArchives
- 2025: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2024: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
